Thus, lytic agents -- which are more readily available -- continue to play a very prominent role in the management of STEMI. [33] Fibrinolytic therapy can be administered in most centers within 30 ...

CAR T cell therapy revolutionizes oncology by using engineered T cells to target and eliminate cancer cells, improving ...